Applications of Glycyl-L-Alanine in Industrial Manufacturing

Glycyl-L-Alanine finds important application in selective industrial segments, meeting precise formulation and processing needs. As a direct manufacturer, we enable professional users to integrate this dipeptide into critical downstream workflows with consistency and regulatory conformity.

1. Peptide-Based Pharmaceutical Intermediates

This material serves as a fundamental building block in the synthesis of peptide drug substances. Its use allows fine control in stepwise peptide elongation and terminal protection strategies. Control of purity and traceability remains critical for GMP manufacturing. The compound fits into solution-phase and solid-phase peptide synthesis lines, offering reliable amide bond formation and being removed efficiently post-coupling. Quality monitoring is conducted using HPLC and mass spectrometry throughout production, leading to APIs with validated safety and activity.

Industry compliance standards

• ICH Q7A Good Manufacturing Practice for Active Pharmaceutical Ingredients
• Ph. Eur. (European Pharmacopoeia) standards for peptide intermediates
• US FDA 21 CFR Part 210, 211 (for drug manufacturing controls)
• ChP (Chinese Pharmacopoeia) purity requirements

Typical usage ratio

• Applied at 0.5–4.0 molar equivalents per coupling step, adjusted to peptide chain length and scale
• Stoichiometry may shift based on efficiency of coupling reagents used in specific process (HATU, DIC, DCC, etc.)

Downstream process integration

• Integrated at the amino acid activation and coupling stage during linear or branched peptide assembly
• Undergoes purification post-coupling, prior to final crude peptide deprotection
• Traced in both in-process and final quality testing using validated analytical methods

Final product types

• Therapeutic peptide APIs (e.g., oligopeptides for metabolic and oncology drugs)
• Peptide-based excipients for injectable formulations
• Peptidomimetic drug candidates

2. Cell Culture Media Supplementation

Manufacturers utilize this dipeptide to supplement amino acid content in chemically defined cell culture media. Its controlled addition improves nutrient stability and mitigates spontaneous degradation associated with free amino acids. The compound enters at the media formulation stage, undergoing filtration to ensure sterility and compatibility with cell line requirements. Quality managers monitor its presence within strict quantitative and contaminant specifications, supporting high-yield recombinant protein manufacturing for further purification.

Industry compliance standards

• ISO 13485:2016 for raw materials in medical device or bioprocess supply
• USP Chapter <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
• GMP EU Guidelines Part IV for Excipients
• Animal-free raw material assertions required for biologics manufacture

Typical usage ratio

• Ranged from 0.2 g/L to 2.5 g/L depending on cell type, protein yield, and feeding frequency
• Dosing based on L-alanine and glycine residual demand in the specific production cell line

Downstream process integration

• Blended during the base medium preparation and sterile filtration step
• Maintained traceability for batch record compliance
• Concentration monitored using amino acid analysis pre-inoculation

Final product types

• Recombinant monoclonal antibodies
• Therapeutic proteins (e.g., erythropoietin, insulin analogs)
• Cell therapy intermediates

3. Specialty Food Additive Blends

Food ingredient manufacturers employ this product as a specialty amino acid source and taste modulation agent in nutritional supplement formulations. It functions under food safety systems, ensuring no protein allergen or cross-contaminant risk. Process engineers add it during premix manufacturing, facilitating controlled release in powder and enteric-coated food matrixes. Finished blends undergo rigorous analytical verification, including amino acid content, microbial quality, and labeling compliance with local and international food regulations.

Industry compliance standards

• FAO/WHO Codex Alimentarius food additive monographs
• GB 2760 National Food Safety Standard for Food Additives (China)
• EU Regulation (EC) No 1333/2008 on food additives
• US 21 CFR Part 172 – Food Additives Permitted

Typical usage ratio

• Used at 0.05%–0.3% (w/w) in functional food powders, meal replacements, or sports supplements
• Level determined by flavor target and applicable national limits for peptide additives

Downstream process integration

• Incorporated during blending of dry nutrient premixes or during aqueous phase dissolution for beverages
• Homogeneity validated by HPLC or total nitrogen determination
• Batch coding in place for trace-back during food recall or audit

Final product types

• Sports nutrition powders
• Enteral medical nutrition blends
• Infant formula amino acid premixes (as permitted by regulation)

4. Analytical Standard Preparation

Chemical and life science laboratories use this dipeptide as an accurate calibration standard for amino acid and peptide quantification by HPLC, LC-MS/MS, or capillary electrophoresis. The material’s high purity and reliable lot-to-lot composition support precise establishment of calibration curves for laboratory quality control or research applications. Procedures require traceability to primary reference materials, verification of purity, and storage under inert atmosphere to prevent hydrolysis or racemization between use intervals.

Industry compliance standards

• ISO 17025:2017 (Testing and Calibration Laboratories)
• NIST/NIBSC reference standards traceability guidelines
• GLP (Good Laboratory Practice) guidelines for reference compounds
• USP general chapters on reference standards

Typical usage ratio

• Stock solutions prepared at 0.1–1.0 mg/mL, depending on the analytical technique and method sensitivity
• Dilutions prepared freshly to match the calibration needs per specific testing method

Downstream process integration

• Weighing and dissolution during preparation of working and standard solutions for HPLC/LC-MS/MS runs
• Values entered into LIMS (Laboratory Information Management Systems) for traceable documentation
• Material recorded on Certificate of Analysis batches for third party validation

Final product types

• Analytical calibration kits for amino acid/peptide quantification
• Quality control reference standards for in-house assay development
• Proficiency test standards for laboratory accreditation

5. Diagnostic Reagent Synthesis

Producers of clinical in vitro diagnostic (IVD) reagents incorporate this dipeptide as a substrate in specific enzymatic assay kits. Its stable structure allows controlled measurement of dipeptidase and aminopeptidase activity in blood or tissue samples. The material is critical at the reagent manufacturing stage, where purity and batch-to-batch consistency are strictly monitored under cGMP-like conditions. Careful formulation reduces detection background and assures reproducibility in clinical laboratories and automated analyzers. Validation of reagent lots aligns with clinical calibration standards and quality controls stipulated by international IVD directives.

Industry compliance standards

• IVDR (EU In Vitro Diagnostic Regulation 2017/746)
• US FDA 21 CFR Part 820 (Quality System Regulation for Medical Devices)
• ISO 13485:2016 for diagnostic reagent manufacturing
• CLSI (Clinical and Laboratory Standards Institute) procedures for QC in clinical diagnostics

Typical usage ratio

• Used at 0.1–1.5 mM in reagent buffer solutions, depending on the target enzyme activity and assay sensitivity
• Ratio customized based on enzyme substrate affinity in validated assay protocols

Downstream process integration

• Added during aqueous buffer formulation under controlled temperature and pH
• Stability evaluated over intended shelf life using lot-release specifications
• Integrated into lyophilized or ready-to-use liquid diagnostic kits

Final product types

• Clinical enzyme assay kits
• Automated chemistry analyzer reagents
• Rapid diagnostic test solutions for disease detection